Monday, April 4, 2016

BRIEF-Flexion reports positive data from zilretta phase 2b, phase 3 clinical trials

* Announces presentation of results from pivotal phase 2b and phase 3 clinical trials for zilretta

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)